CINECA IRIS Institutional Research Information System

PAPOTTI, Mauro Giulio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.820
EU - Europa 17.465
AS - Asia 10.452
SA - Sud America 701
OC - Oceania 290
AF - Africa 245
Continente sconosciuto - Info sul continente non disponibili 32
Totale 56.005
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.981
CN - Cina 4.899
IT - Italia 4.113
DE - Germania 1.863
IE - Irlanda 1.862
SG - Singapore 1.578
FR - Francia 1.548
SE - Svezia 1.495
UA - Ucraina 1.260
GB - Regno Unito 1.037
FI - Finlandia 1.015
KR - Corea 941
CA - Canada 659
JP - Giappone 655
IN - India 623
PL - Polonia 613
AT - Austria 603
VN - Vietnam 454
BR - Brasile 391
ES - Italia 388
TR - Turchia 328
NL - Olanda 301
AU - Australia 260
DK - Danimarca 217
ID - Indonesia 211
RU - Federazione Russa 179
BE - Belgio 172
HK - Hong Kong 165
MX - Messico 158
GR - Grecia 156
TW - Taiwan 128
AR - Argentina 120
CH - Svizzera 115
RO - Romania 106
PT - Portogallo 100
SN - Senegal 85
CO - Colombia 73
CZ - Repubblica Ceca 70
IL - Israele 61
SA - Arabia Saudita 54
CL - Cile 53
PH - Filippine 52
TH - Thailandia 52
NO - Norvegia 49
MY - Malesia 45
HU - Ungheria 44
PK - Pakistan 43
EG - Egitto 39
UZ - Uzbekistan 35
EU - Europa 31
HR - Croazia 29
NZ - Nuova Zelanda 29
RS - Serbia 29
IR - Iran 28
ZA - Sudafrica 28
DZ - Algeria 27
SI - Slovenia 25
AE - Emirati Arabi Uniti 24
PE - Perù 21
EC - Ecuador 19
SK - Slovacchia (Repubblica Slovacca) 17
VE - Venezuela 15
BG - Bulgaria 13
MU - Mauritius 13
MA - Marocco 11
NG - Nigeria 11
AM - Armenia 10
IQ - Iraq 9
TN - Tunisia 9
BY - Bielorussia 8
JO - Giordania 8
KZ - Kazakistan 8
MK - Macedonia 8
LT - Lituania 7
GT - Guatemala 6
BA - Bosnia-Erzegovina 5
PR - Porto Rico 5
SC - Seychelles 5
SD - Sudan 5
CY - Cipro 4
LB - Libano 4
LU - Lussemburgo 4
OM - Oman 4
PY - Paraguay 4
QA - Qatar 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
BD - Bangladesh 3
EE - Estonia 3
GE - Georgia 3
KW - Kuwait 3
LK - Sri Lanka 3
LV - Lettonia 3
PA - Panama 3
CI - Costa d'Avorio 2
CU - Cuba 2
HN - Honduras 2
MT - Malta 2
PS - Palestinian Territory 2
RE - Reunion 2
Totale 55.977
Salva come PNG Salva come JPEG
Città #
Chandler 2.630
Beijing 2.572
Dublin 1.828
Houston 1.749
Fairfield 1.447
Singapore 1.191
Ann Arbor 1.087
Ashburn 1.030
Torino 930
Wilmington 869
Jacksonville 819
Redwood City 800
Villeurbanne 751
Woodbridge 741
Seattle 624
Medford 597
Princeton 578
Vienna 565
Columbus 557
Nyköping 515
Cambridge 514
Santa Clara 489
Dearborn 488
Warsaw 485
Pisa 423
Fremont 327
Milan 323
Turin 301
Boston 284
Shanghai 244
Guangzhou 239
Dong Ket 225
New York 213
Boardman 192
Nanjing 180
Jakarta 179
Toronto 169
Tokyo 167
Munich 154
Verona 146
Hangzhou 140
Rome 128
Seoul 114
Norwalk 105
Pune 105
Chicago 104
San Diego 100
Washington 96
Düsseldorf 93
Montréal 90
Helsinki 88
Brussels 86
Chengdu 81
Tappahannock 79
London 78
Madrid 78
Falls Church 74
Wuhan 74
Los Angeles 73
São Paulo 69
Würzburg 69
Zhengzhou 69
Hefei 67
Lachine 67
Paris 67
Shenyang 67
Phoenix 66
Taipei 66
Bologna 63
Jinan 63
Mcallen 63
Mountain View 62
Ottawa 59
Kunming 56
Ankara 55
Pittsburgh 55
Silver Spring 55
Buenos Aires 54
Istanbul 53
Rochester 53
Athens 51
Changsha 51
New Delhi 48
Central District 47
Santiago 46
Amsterdam 43
Birmingham 43
Dallas 42
Hebei 42
Barcelona 41
Bethesda 40
Moscow 40
Hong Kong 39
Honolulu 39
Padova 39
Canberra 38
Florence 36
Philadelphia 36
Sydney 36
Chongqing 34
Totale 31.537
Salva come PNG Salva come JPEG
Nome #
The weiss score and beyond--histopathology for adrenocortical carcinoma. 1.383
The Reticulin Algorithm for Adrenocortical Tumor Diagnosis: A Multicentric Validation Study on 245 Unpublished Cases. 1.101
CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma 1.034
Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology 878
Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. 801
Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma 692
Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior. 668
What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms? 588
β1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells. 520
Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are applied 467
Morgana acts as an oncosuppressor in chronic myeloid leukemia. 442
Eccrine spiradenoma of the nipple: Case report, differential diagnosis and literature review 441
Oncocytic Adrenocortical Tumors: Diagnostic Algorithm and Mitochondrial DNA Profile in 27 Cases. 437
Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer 430
Renal oncocytosis: a clinicopathological and cytogenetic study of 42 tumours occurring in 11 patients 418
Tumor staging but not grading is associated with adverse clinical outcome in neuroendocrine tumors of the appendix: a retrospective clinical pathologic analysis of 138 cases. 416
Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart 403
Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas 385
Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation. 383
Extrapulmonary neuroendocrine small and large cell carcinomas: a review of controversial diagnostic and therapeutic issues. 381
Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm 342
RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact 339
The roles of multiparametric magnetic resonance imaging, PCA3 and prostate health index - Which is the best predictor of prostate cancer after a negative biopsy? 339
Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification. 329
Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines 326
Molecular and Histological Changes in Post-Treatment Biopsies of Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Study 319
Prognostic Role of Overt Hypercortisolism in Completely Operated Patients with Adrenocortical Cancer 317
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors 314
microRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations 313
Mesothelioma families without inheritance of a BAP1 predisposing mutation 307
Detection of EGFR mutations in archival lung cancer samples by pyrosequencing 306
An international Ki67 reproducibility study in adrenal cortical Carcinoma 299
Therapeutic Biomarkers in Lung Neuroendocrine Neoplasia 298
The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations 296
Core biopsies of renal masses: a safe and accurate tool for managing all that is indeterminate 291
Pathology of the Adrenal Cortex: a Reappraisal of the Past 25 Years Focusing on Adrenal Cortical Tumors. 278
Poorly differentiated thyroid carcinoma: 5 years after the 2004 WHO classification of endocrine tumours. 276
Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates 276
Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis 275
Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study. 266
The potential of combined immunotherapy and antiangiogenesis for the synergistic treatment of advanced NSCLC. 261
Expression of cortistatin and MrgX2, a specific cortistatin receptor, in human neuroendocrine tissues and related tumours 256
Potential diagnostic and prognostic role of micro-environment in malignant pleural mesothelioma 254
Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases. 252
RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization 249
Adjuvant mitotane treatment for adrenocortical carcinoma 245
Mammalian target of rapamycin pathway activation is associated to RET mutation status in medullary thyroid carcinoma. 240
Differential expression of HER2, STAT3, SOX2, IFI16 and cell cycle markers during HPV-related head and neck carcinogenesis 240
MEN1 Gene Mutation and Reduced Expression Are Associated with Poor Prognosis in Pulmonary Carcinoids 237
Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines. 235
Morgana is a new oncosuppressor in CML 232
Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma 230
Retrospective multicenter study investigating the role of targeted next-generation sequencing of selected cancer genes in mucinous adenocarcinoma of the lung 225
Effects of sub-chronic nandrolone administration on hormonal adaptive response to acute stress in rats. 218
Validation of the diagnosis of mesothelioma and BAP1 protein expression in a cohort of asbestos textile workers from Northern Italy 211
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 210
ELOVL5 Mutations Cause Spinocerebellar Ataxia 38 207
YKL-40/c-Met Expression in Rectal Cancer Biopsies Predicts Tumor Regression following Neoadjuvant Chemoradiotherapy: A Multi-Institutional Study 207
Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up 206
mTORC1 Complex is Significantly Over-Activated in SDHX-Mutated Paragangliomas 201
ATF2 contributes to cisplatin resistance in non-small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK/ATF2 pathway. 197
Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation 195
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma 193
H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features data from a multi-institutional series 192
Differentiation-inducing factor 1 enhances 5-fluorouracil action on oral cancer cells inhibiting E2F1 and Thymidylate Synthase mRNAs accumulation 190
Brca1-Associated Protein 1 (BAP1) Immunohistochemical Expression as a Diagnostic Tool in Malignant Pleural Mesothelioma Classification: a Large Retrospective Study 190
Dasatinib modulates sensitivity to pemetrexed in malignant pleural mesothelioma cell lines 190
Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lung. 189
Impact of COVID-19 lockdown measures on oncological surgical activity: Analysis of the surgical pathology caseload of a tertiary referral hospital in Northwestern Italy 187
Distinctive pathological and clinical features of lung carcinoids with high proliferation index 186
Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma 179
Detection and characterization of classical and "uncommon" exon 19 Epidermal Growth Factor Receptor mutations in lung cancer by pyrosequencing 179
Why castration-resistant prostate cancer patients with neuroendocrine differentiation should be addressed to a cisplatin-based regimen 178
Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: A multicentre cohort study 173
Effects of Src kinase inhibition induced by dasatinib in non-small cell lung cancer cell lines treated with cisplatin 169
Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer 169
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study. 168
Utilility of flow cytometry as ancillary study to improve the cytologic diagnosis of thyroid lymphomas 168
Increased neuroendocrine cells in resected metastases compared to primary colorectal adenocarcinomas. 166
CAVEOLIN-1 expression in brain metastasis from lung cancer predicts worse outcome and radioresistance, irrespective of tumor histotype 165
Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas 165
A DNA vaccine against ERBB2 impairs chemical carcinogenesis in random-bred hamsters 161
ACYLATED AND UNACYLATED GHRELIN PROMOTE PROLIFERATION AND INHIBIT SERUM STARVATION- AND CYTOKINE-INDUCED APOPTOSIS OF PANCREATIC BETA-CELLS AND HUMAN ISLETS. INVOLVEMENT OF cAMP/PKA, ERK1/2 AND PI3K/AKT SIGNALING 159
Precision medicine in age-specific non-small-cell-lung-cancer patients: Integrating biomolecular results into clinical practice-A new approach to improve personalized translational research. 158
Aurora Kinase A expression is associated with lung cancer histological-subtypes and with tumor de-differentiation. 150
ALK Rearrangement Testing by FISH Analysis in Non-Small-Cell Lung Cancer Patients: Results of the First Italian External Quality Assurance Scheme. 149
Progressive increase of matrix metalloprotease-9 and interleukin-8 serum levels during carcinogenic process in human colorectal tract 148
Large cell carcinoma of the lung: A tumor in search of an author. A clinically oriented critical reappraisal 146
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: A multicenter interobserver variation analysis using virtual microscopy: A Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T) 146
Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide. 144
Classification of pulmonary neuroendocrine tumors: New insights 142
mTOR/p70S6K in Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia. 140
RFamide peptides 43RFa and 26RFa both promote survival of pancreatic β-cells and human pancreatic islets but exert opposite effects on insulin secretion. 136
Impact of non-small-cell lung cancer-not otherwise specified immunophenotyping on treatment outcome. 135
Current state-of-the-art therapy for advanced squamous cell lung cancer 135
Synergistic activation upon MET and ALK coamplification sustains targeted therapy in sarcomatoid Carcinoma, a deadly subtype of lung cancer 133
Safety and diagnostic performance of image-guided lung biopsy in the targeted therapy era 129
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer 128
PAX8–GLIS3 gene fusion is a pathognomonic genetic alteration of hyalinizing trabecular tumors of the thyroid 128
Ribonucleotide Reductase Large Subunit (RRM1) Gene Expression May Predict Efficacy of Adjuvant Mitotane in Adrenocortical Cancer. 126
Totale 29.471
Salva come PNG Salva come JPEG
Categoria #
all - tutte 157.941
article - articoli 0
book - libri 0
conference - conferenze 11.355
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 169.296
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.447 0 0 0 0 748 1.441 1.002 655 856 713 615 417
2020/20216.665 578 455 587 389 591 495 602 376 667 623 489 813
2021/20226.619 336 377 372 474 358 349 478 412 287 469 1.334 1.373
2022/20239.107 924 626 227 882 857 2.266 714 576 974 249 460 352
2023/20244.783 588 779 340 276 323 591 208 276 58 278 399 667
2024/20254.060 221 892 470 1.113 1.364 0 0 0 0 0 0 0
Totale 57.885